OTC Markets OTCPK - Delayed Quote USD

Syros Pharmaceuticals, Inc. (SYRS)

0.0223
-0.0016
(-6.89%)
At close: June 12 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
386
9,936
14,880
23,488
15,093
Operating Expense
111,908
136,435
141,243
122,908
97,390
Operating Income
-111,522
-126,499
-126,363
-99,420
-82,297
Net Non Operating Interest Income Expense
-623
1,689
-2,002
-3,820
-1,366
Other Income Expense
14,330
-39,764
33,711
16,682
-375
Pretax Income
-97,815
-164,574
-94,654
-86,558
-84,038
Net Income Common Stockholders
-97,815
-164,574
-94,654
-86,558
-84,038
Diluted NI Available to Com Stockholders
-97,815
-164,574
-94,654
-86,558
-84,038
Basic EPS
-3.07
-5.81
-7.49
-13.84
-18.20
Diluted EPS
-3.07
-5.81
-7.49
-13.84
-18.20
Basic Average Shares
36,785.0160
28,325.7790
12,631.9680
6,253.4980
4,605.1620
Diluted Average Shares
36,785.0160
28,325.7790
12,631.9680
6,253.4980
4,605.1620
Total Operating Income as Reported
-111,657
-128,988
-135,873
-99,420
-82,297
Total Expenses
111,908
136,435
141,243
122,908
97,390
Net Income from Continuing & Discontinued Operation
-97,815
-164,574
-94,654
-86,558
-84,038
Normalized Income
-112,145
-124,810
-128,365
-103,240
-83,663
Interest Income
4,707
6,816
2,132
87
426
Interest Expense
5,330
5,127
4,134
3,907
1,792
Net Interest Income
-623
1,689
-2,002
-3,820
-1,366
EBIT
-92,485
-159,447
-90,520
-82,651
-82,246
EBITDA
-91,143
-157,195
-87,814
-79,633
-79,211
Reconciled Depreciation
1,342
2,252
2,706
3,018
3,035
Net Income from Continuing Operation Net Minority Interest
-97,815
-164,574
-94,654
-86,558
-84,038
Total Unusual Items Excluding Goodwill
14,330
-39,764
33,711
16,682
-375
Total Unusual Items
14,330
-39,764
33,711
16,682
-375
Normalized EBITDA
-105,473
-117,431
-121,525
-96,315
-78,836
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 6/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIRX Viracta Therapeutics, Inc.
0.0200
0.00%
 
XLO Xilio Therapeutics, Inc.
0.6624
-3.10%
 
MCRB Seres Therapeutics, Inc.
7.50
-6.13%
 
PSTV Plus Therapeutics, Inc.
0.3140
-10.08%
 
TOVX Theriva Biologics, Inc.
0.4797
-3.98%
 
APLT Applied Therapeutics, Inc.
0.3540
-3.01%
 
VINC Vincerx Pharma, Inc.
0.0550
-6.78%
 
VRCA Verrica Pharmaceuticals Inc.
0.6231
-7.52%
 
ONCO Onconetix, Inc.
4.7300
-24.90%
 
DRMA Dermata Therapeutics, Inc.
0.7123
-2.96%